Jan Grimm

Jan Grimm is the current Chief Scientific Officer at Neurimmune Holding. Jan has over fifteen years of experience in the scientific field, with a focus on Alzheimer's research. Jan started their career as a scientist at Rinat Neuroscience Corporation in 2001. Jan quickly rose through the ranks and became the Head of Alzheimer's Research in 2003. Jan held this position until 2006 when they left to join Neurimmune Holding. Jan has made significant contributions to the scientific community and is highly respected in their field.

Jan Grimm received their Ph.D. in Molecular Biology from the Max Delbrück Center, their M.Sc. in Molecular Biology from The Julius Maximilians University of Würzburg, and their B.Sc. in Molecular Biology from The University of Texas at Austin.

Jan Grimm reports to Roger M Nitsch, CEO. Some of their coworkers include Fabian Buller - Chief Business Officer, Christoph Hock - Chief Medical Officer, and Dirk Schimkat - CFO.